REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bp Synergy Pharm Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Bp Synergy Pharm Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Trading in medical instrument, medical equipment, medical test kit, healthcare, medical disposal items & health supplements, business that the company might think fit or necessary and tranportation agent. investment holding

Headquarters
33, Jalan Perniagaan Vorteks 5, Pusat Perniagaan Vorteks
Simpang Ampat; Penang; Postal Code: 14100

Contact Details: Purchase the Bp Synergy Pharm Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Bp Synergy Pharm Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Bp Synergy Pharm Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Bp Synergy Pharm Sdn. Bhd. report to view the information.
Incorporation Date:
March 10, 2010
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Bp Synergy Pharm Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-0.4%▼
Total operating revenue
-0.4%▼
Operating profit (EBIT)
-17.48%▼
Net Profit (Loss) for the Period
-24.71%▼
Total assets
13.42%▲
Total equity
21.69%▲
Operating Profit Margin (ROS)
-2.33%▼
Net Profit Margin
-2.8%▼
Return on Equity (ROE)
-10.98%▼
Quick Ratio
0.61%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo